2 Top Healthcare Stocks Defying the Bear Market
These pharmaceutical companies are expected to see a big rise in revenue, thanks to new therapies.
Source: fool.com
Page 27 - Andrew Baum News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Andrew Baum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Andrew Baum Today - Breaking & Trending Today
Eli Lilly's Alzhiemer's Drug Shows Potential in Final Trials
The World Health Organization picked 2030 as a seemingly random stretch goal for finding a cure for the global scourge that is Alzheimer's...
Source: fool.com
Pfizer (PFE) Q1 2023 Earnings Call Transcript
PFE earnings call for the period ending March 31, 2023.
Source: fool.com
Eli Lilly drug slows Alzheimer's disease, study finds
The success means patients and their caregivers could soon have another therapy shown to slow the disease alongside Leqembi — made by Cambridge biotech Biogen and Japanese drug maker Eisai — which was approved in January.
Source: bostonglobe.com
Eli Lilly says experimental drug slows decline from Alzheimer's – Indianapolis Business Journal
If approved, Donanemab has annual multi-billion-dollar sales potential. Lilly shares rose 6% in early-afternoon trading.
Source: ibj.com